Username

Password

Preview

Sign-in free and Explore the Exciting World of BiomedExperts:

Over 1.500.000 Profiles
More than 1.800 Organizations worldwide
State of the Art Network Visualizations

Manage your own Profile
Locate Experts in your Country/Region
Locate Experts in your 1. and 2. Level Network
Connect to Experts Worldwide

NetworkView

Anton Martens

This is a preview profile on BiomedExperts - the first literature-based scientific social network. It brings the right researchers together and allows them to collaborate online. Collexis and Dell provide the BiomedExperts network of +1.5 Million pre-calculated profiles free of charge to researchers worldwide.

Research Profile (preview)

Living Beings

Disorders

Procedures

Anatomy

Chemicals & Drugs

Cyclophosphamide

Physiology

Sign-in to see full Profile

Sign-in to see all Coauthors

Publications

TOP 3
Swart Joost; Martens Anton; Wulffraat Nico
Mesenchymal stem cells: a future for the treatment of arthritis?
Rozemuller Henk; van der Spek Ellen; Bogers-Boer Lijnie H; Zwart Mieke C; Verweij Vivienne; Emmelot Maarten; Groen Richard W; Spaapen Robbert; Bloem Andries C; Lokhorst Henk M; Mutis Tuna; Martens Anton C
A bioluminescence imaging based in vivo model for preclinical testing of novel cellular immunotherapy strategies to improve the graft-versus-myeloma effect.
Olivo Cristina; Alblas Jacqueline; Verweij Vivienne; Van Zonneveld Anton-Jan; Dhert Wouter J A; Martens Anton C M
In vivo bioluminescence imaging study to monitor ectopic bone formation by luciferase gene marked mesenchymal stem cells.

Sign-in to see all Publications

Sign in free and see...

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the visualized research activity
of experts around the globe

Sign-in to see more

Geonetwork of Anton Martens (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

Sign-in to see more

All Publications

2008: Swart Joost; Martens Anton; Wulffraat Nico
Mesenchymal stem cells: a future for the treatment of arthritis?
Joint, bone, spine : revue du rhumatisme 2008;75(4):379-82.
2008: Rozemuller Henk; van der Spek Ellen; Bogers-Boer Lijnie H; Zwart Mieke C; Verweij Vivienne; Emmelot Maarten; Groen Richard W; Spaapen Robbert; Bloem Andries C; Lokhorst Henk M; Mutis Tuna; Martens Anton C
A bioluminescence imaging based in vivo model for preclinical testing of novel cellular immunotherapy strategies to improve the graft-versus-myeloma effect.
Haematologica 2008;93(7):1049-57.
2008: Olivo Cristina; Alblas Jacqueline; Verweij Vivienne; Van Zonneveld Anton-Jan; Dhert Wouter J A; Martens Anton C M
In vivo bioluminescence imaging study to monitor ectopic bone formation by luciferase gene marked mesenchymal stem cells.
Journal of orthopaedic research : official publication of the Orthopaedic Research Society 2008;26(7):901-9.
2008: Siddappa Ramakrishnaiah; Martens Anton; Doorn Joyce; Leusink Anouk; Olivo Cristina; Licht Ruud; van Rijn Linda; Gaspar Claudia; Fodde Riccardo; Janssen Frank; van Blitterswijk Clemens; de Boer Jan
cAMP/PKA pathway activation in human mesenchymal stem cells in vitro results in robust bone formation in vivo.
Proceedings of the National Academy of Sciences of the United States of America 2008;105(20):7281-6.
2008: Roord Sarah T A; de Jager Wilco; Boon Louis; Wulffraat Nico; Martens Anton; Prakken Berent; van Wijk Femke
Autologous bone marrow transplantation in autoimmune arthritis restores immune homeostasis through CD4+CD25+Foxp3+ regulatory T cells.
Blood 2008;111(10):5233-41.
2008: Nestvold Janne M; Omdal Bente K; Dai Ke-Zheng; Martens Anton; Benestad Haakon B; Vaage John T; Rolstad Bent
A second prophylactic MHC-mismatched bone marrow transplantation protects against rat acute myeloid leukemia (BNML) without lethal graft-versus-host disease.
Transplantation 2008;85(1):102-11.
2007: van Rijn Rozemarijn S; Simonetti Elles R; Hagenbeek Anton; Bonyhadi Mark; Storm Gert; Martens Anton C M; Ebeling Saskia B
Quantitative assessment of human T lymphocytes in RAG2(-/-)gammac(-/-) mice: the impact of ex vivo manipulation on in vivo functionality.
Experimental hematology 2007;35(1):117-27.
2006: Mutis Tuna; van Rijn Rozemarijn S; Simonetti Elles R; Aarts-Riemens Tineke; Emmelot Maarten E; van Bloois Louis; Martens Anton; Verdonck Leo F; Ebeling Saskia B
Human regulatory T cells control xenogeneic graft-versus-host disease induced by autologous T cells in RAG2-/-gammac-/- immunodeficient mice.
Clinical cancer research : an official journal of the American Association for Cancer Research 2006;12(18):5520-5.
2004: Smakman Niels; Martens Anton; Kranenburg Onno; Borel Rinkes Inne H M
Validation of bioluminescence imaging of colorectal liver metastases in the mouse.
The Journal of surgical research 2004;122(2):225-30.
2004: Rozemuller Henk; Knaän-Shanzer Shosh; Hagenbeek Anton; van Bloois Louis; Storm Gert; Martens Anton C M
Enhanced engraftment of human cells in RAG2/gammac double-knockout mice after treatment with CL2MDP liposomes.
Experimental hematology 2004;32(11):1118-25.
2004: Weijtens Mo; van Spronsen Anke; Hagenbeek Anton; de Weger Roel; Martens Anton
Ganciclovir-mediated elimination of HSV-Tk+ T cells and cure of graft-vs-host disease in an allogeneic bone marrow transplantation model in the rat.
Experimental hematology 2004;32(10):962-9.
2004: Kruyt M C; Stijns M M C; Fedorovich N E; De Bruijn J D; Van Blitterswijk C A; Verbout A J; Rozemuller H; Hagenbeek A; Dhert W J A; Martens A C M
Genetic marking with the DeltaLNGFR-gene for tracing goat cells in bone tissue engineering.
Journal of orthopaedic research : official publication of the Orthopaedic Research Society 2004;22(4):697-702.
2004: Moore Jennifer C; Spijker Rene; Martens Anton C; de Boer Teun; Rook Martin B; van der Heyden Marcel A G; Tertoolen Leon G; Mummery Christine L
A P19Cl6 GFP reporter line to quantify cardiomyocyte differentiation of stem cells.
The International journal of developmental biology 2004;48(1):47-55.
2003: van Rijn Rozemarijn S; Simonetti Elles R; Hagenbeek Anton; Hogenes Marieke C H; de Weger Roel A; Canninga-van Dijk Marijke R; Weijer Kees; Spits Hergen; Storm Gert; van Bloois Louis; Rijkers Ger; Martens Anton C M; Ebeling Saskia B
A new xenograft model for graft-versus-host disease by intravenous transfer of human peripheral blood mononuclear cells in RAG2-/- gammac-/- double-mutant mice.
Blood 2003;102(7):2522-31.
2003: Rookmaaker Maarten B; Smits Anke M; Tolboom Herman; Van 't Wout Karin; Martens Anton C; Goldschmeding Roel; Joles Jaap A; Van Zonneveld Anton Jan; Gröne Herman-Joseph; Rabelink Ton J; Verhaar Marianne C
Bone-marrow-derived cells contribute to glomerular endothelial repair in experimental glomerulonephritis.
The American journal of pathology 2003;163(2):553-62.
2003: Ferrand Christophe; Perruche Sylvain; Robinet Eric; Martens Anton; Tiberghien Pierre; Saas Philippe
How should chimerism be decoded?
Transplantation 2003;75(9 Suppl):50S-54S.
2003: Bonini C; Grez M; Traversari C; Ciceri F; Marktel S; Ferrari G; Dinauer M; Sadat M; Aiuti A; Deola S; Radrizzani M; Hagenbeek A; Apperley J; Ebeling S; Martens A; Kolb H J; Weber M; Lotti F; Grande A; Weissinger E; Bueren J A; Lamana M; Falkenburg J H F; Heemskerk M H M; Austin T; Kornblau S; Marini F; Benati C; Magnani Z; Cazzaniga S; Toma S; Gallo-Stampino C; Introna M; Slavin S; Greenberg P D; Bregni M; Mavilio F; Bordignon C
Safety of retroviral gene marking with a truncated NGF receptor.
Nature medicine 2003;9(4):367-9.
2003: Kolen Sebastianus; Weijtens Mo; Hagenbeek Anton; van Spronsen Anke; Smulders Saskia; de Weger Roel; de Witte Theo; Dolstra Harry; van de Wiel van Kemenade Elly; Martens Anton
Monitoring of developing graft-versus-host disease mediated by herpes simplex virus thymidine kinase gene-transduced T cells.
Human gene therapy 2003;14(4):341-51.
2002: Weijtens Mo; van Spronsen Anke; Hagenbeek Anton; Braakman Eric; Martens Anton
Reduced graft-versus-host disease-inducing capacity of T cells after activation, culturing, and magnetic cell sorting selection in an allogeneic bone marrow transplantation model in rats.
Human gene therapy 2002;13(2):187-98.
2000: Rombouts W J; Martens A C; Ploemacher R E
Identification of variables determining the engraftment potential of human acute myeloid leukemia in the immunodeficient NOD/SCID human chimera model.
Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K 2000;14(5):889-97.
2000: El-Beltagi H M; Martens A C; Hagenbeek A
Leukemia cell lines resistant to cytosine arabinoside, cyclophosphamide or daunomycin are equally sensitive to the drug acetyldinaline as the parental cell line.
Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K 2000;14(1):213-4.
1999: Rombouts W J; Broyl A; Martens A C; Slater R; Ploemacher R E
Human acute myeloid leukemia cells with internal tandem duplications in the Flt3 gene show reduced proliferative ability in stroma supported long-term cultures.
Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K 1999;13(7):1071-8.
1999: Braakman E; Vogels R; Martens A C; Vermeulen J; Bron M; Hoogerbrugge P M; Valerio D; Hagenbeek A
Ganciclovir-mediated in vivo elimination of myeloid leukemic cells expressing the HSVtk gene induces HSVtk loss variants.
Gene therapy 1999;6(6):1139-46.
1999: Martens A C; Hagenbeek A
Amifostine (WR2721) for dose escalation in marrow-ablative treatment of leukaemia.
European journal of cancer (Oxford, England : 1990) 1999;35(4):634-40.
1998: Rozemuller H; Terpstra W; Rombouts E J; Lawler M; Byrne C; FitzGerald D J; Kreitman R J; Wielenga J J; Löwenberg B; Touw I P; Hagenbeek A; Martens A C
GM-CSF receptor targeted treatment of primary AML in SCID mice using Diphtheria toxin fused to huGM-CSF.
Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K 1998;12(12):1962-70.
1998: Rozemuller H; Rombouts E J; Touw I P; FitzGerald D J; Kreitman R J; Hagenbeek A; Martens A C
In vivo targeting of leukemic cells using diphtheria toxin fused to murine GM-CSF.
Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K 1998;12(5):710-7.
1998: Gowing H; Braakman E; Hagenbeek A; Lawler M; McCann S R; Pamphilon D H; Martens A C
Influence of ultraviolet-B irradiation on engraftment, graft-versus-host disease and graft-versus-leukemia effect in a rat model for allogeneic bone marrow transplantation.
Bone marrow transplantation 1998;21(8):801-7.
1997: Terpstra W; Rozemuller H; Breems D A; Rombouts E J; Prins A; FitzGerald D J; Kreitman R J; Wielenga J J; Ploemacher R E; Löwenberg B; Hagenbeek A; Martens A C
Diphtheria toxin fused to granulocyte-macrophage colony-stimulating factor eliminates acute myeloid leukemia cells with the potential to initiate leukemia in immunodeficient mice, but spares normal hemopoietic stem cells.
Blood 1997;90(9):3735-42.
1997: Jansen M W; Brandenburg H; Wildschut H I; Martens A C; Hagenaars A M; Wladimiroff J W; in 't Veld P A
The effect of chorionic villus sampling on the number of fetal cells isolated from maternal blood and on maternal serum alpha-fetoprotein levels.
Prenatal diagnosis 1997;17(10):953-9.
1997: Rozemuller H; Rombouts E J; Touw I P; FitzGerald D J; Kreitman R J; Pastan I; Hagenbeek A; Martens A C
Sensitivity of human acute myeloid leukaemia to diphtheria toxin-GM-CSF fusion protein.
British journal of haematology 1997;98(4):952-9.
1996: Hendrikx P J; Vermeulen J; Hagenbeek A; Vermey M; Martens A C
LacZ staining in paraffin-embedded tissue sections.
The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society 1996;44(11):1323-9.
1996: Rozemuller H; Rombouts W J; Touw I P; FitzGerald D J; Kreitman R J; Pastan I; Hagenbeek A; Martens A C
Treatment of acute myelocytic leukemia with interleukin-6 Pseudomonas exotoxin fusion protein in a rat leukemia model.
Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K 1996;10(11):1796-803.
1996: Arkesteijn G J; Erpelinck S L; Martens A C; Hagemeijer A; Hagenbeek A
The use of FISH with chromosome-specific repetitive DNA probes for the follow-up of leukemia patients. Correlations and discrepancies with bone marrow cytology.
Cancer genetics and cytogenetics 1996;88(1):69-75.
1996: O'Neill P A; Lawler M; Pullens R; Kloosterman T; Hudson J; Martens A C; Hendrikx P J; Gowing H; Byrne C; Hagenbeek A; Pamphilon D H; McCann S R
PCR amplification of short tandem repeat sequences allows serial studies of chimaerism/engraftment following BMT in rodents.
Bone marrow transplantation 1996;17(2):265-71.
1996: Gowing H; Lawler M; Hagenbeek A; McCann S R; Pamphilon D H; Hudson J; van Weelden H; Braakman E; Martens A C
Effect of ultraviolet-B light on lymphocyte activity at doses at which normal bone marrow stem cells are preserved.
Blood 1996;87(4):1635-43.
1996: Jongen-Lavrencic M; Peeters H R; Rozemuller H; Rombouts W J; Martens A C; Vreugdenhil G; Pillay M; Cox P H; Bijser M; Brutel G; Breedveld F C; Swaak A J
IL-6-induced anaemia in rats: possible pathogenetic implications for anemia observed in chronic inflammations.
Clinical and experimental immunology 1996;103(2):328-34.
1995: Hendrikx P J; Martens A C; Schultz F W; Visser J W; Hagenbeek A
Monitoring of leukemia growth in a rat model using a highly sensitive assay for the detection of LacZ marked leukemic cells.
Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K 1995;9(11):1954-60.
1995: Arkesteijn G J; Erpelinck S L; Martens A C; Hagenbeek A
Chromosome specific DNA hybridization in suspension for flow cytometric detection of chimerism in bone marrow transplantation and leukemia.
Cytometry 1995;19(4):353-60.
1995: Kloosterman T C; Martens A C; van Bekkum D W; Hagenbeek A
Graft-versus-leukemia in rat MHC-mismatched bone marrow transplantation is merely an allogeneic effect.
Bone marrow transplantation 1995;15(4):583-90.
1994: Kloosterman T C; Martens A C; Osterwalder B; Hagenbeek A
Interleukin-2 therapy after allogeneic bone marrow transplantation for acute myelocytic leukemia: studies in a relevant rat model for AML.
Bone marrow transplantation 1994;14(6):965-73.
1994: Hendrikx P J; Martens A C; Visser J W; Hagenbeek A
Differential suppression of background mammalian lysosomal beta-galactosidase increases the detection sensitivity of LacZ-marked leukemic cells.
Analytical biochemistry 1994;222(2):456-60.
1994: Kloosterman T C; Tielemans M J; Martens A C; van Bekkum D W; Hagenbeek A
Quantitative studies on graft-versus-leukemia after allogeneic bone marrow transplantation in rat models for acute myelocytic and lymphocytic leukemia.
Bone marrow transplantation 1994;14(1):15-22.
1994: Xi Y Z; Martens A C; Zsebo K M
[Effects of recombinant stem cell factor on the proliferation in vitro of LT12 acute promyelocytic leukemic cell line]
Zhonghua zhong liu za zhi [Chinese journal of oncology] 1994;16(2):93-7.
1994: de Groot C J; Martens A C; Hagenbeek A
Aldehyde dehydrogenase involvement in a variant of the brown Norway rat acute myelocytic leukaemia (BNML) that acquired cyclophosphamide resistance in vivo.
European journal of cancer (Oxford, England : 1990) 1994;30A(14):2137-43.
1993: el-Beltagi H M; Martens A C; Dahab G M; Hagenbeek A
Efficacy of acetyldinaline for treatment of minimal residual disease (MRD): preclinical studies in the BNML rat model for human acute myelocytic leukemia.
Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K 1993;7(11):1795-800.
1993: el-Beltagi H M; Martens A C; Haroun E A; Hagenbeek A
In vivo development of an acetyldinaline resistant subline of the BN rat acute myelocytic leukemia (BNML).
Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K 1993;7(8):1275-80.
1993: el-Beltagi H M; Martens A C; Lelieveld P; Haroun E A; Hagenbeek A
Acetyldinaline: a new oral cytostatic drug with impressive differential activity against leukemic cells and normal stem cells--preclinical studies in a relevant rat model for human acute myelocytic leukemia.
Cancer research 1993;53(13):3008-14.
1993: Gaiser J F; Kloosterman T C; Martens A C; Hagenbeek A
In vitro resistance of the brown Norway rat acute myelocytic leukemia (BNML) to lymphokine-activated killer activity.
Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K 1993;7(5):736-41.
1993: Yan Y; Martens A C; de Groot C J; Hendrikx P J; Valerio D; van Bekkum D W; Hagenbeek A
Retrovirus-mediated transfer and expression of marker genes in the BN rat acute myelocytic leukemia model for the study of minimal residual disease (MRD).
Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K 1993;7(1):131-9.
1992: Kloosterman T C; Tielemans M J; Martens A C; Hoogerbrugge P M; van Bekkum D W; Hagenbeek A
L4415: further characterization of the rat model for human acute lymphocytic leukemia.
Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K 1992;6(11):1161-6.
1992: Yan Y; Martens A C; Van Bekkum D W
[Minimum residual leukemic cells in genetically marked brown Norway rat myelocytic leukemia model]
Zhonghua zhong liu za zhi [Chinese journal of oncology] 1992;14(6):414-7.
1991: Hagenbeek A; Martens A C
Minimal residual disease in acute leukaemia: preclinical studies in a relevant rat model (BNML).
Baillière's clinical haematology 1991;4(3):609-35.
1991: Chu J; Martens A C; Yan Y; van Bekkum B W; Hagenbeek A
Experimental studies on the elimination of minimal residual leukemia in vivo by alternative half-body irradiation.
Chinese medical sciences journal = Chung-kuo i hsüeh k'o hsüeh tsa chih / Chinese Academy of Medical Sciences 1991;6(1):60.
1991: Martens A C; de Groot C J; Hagenbeek A
Development and characterisation of a cyclophosphamide resistant variant of the BNML rat model for acute myelocytic leukaemia.
European journal of cancer (Oxford, England : 1990) 1991;27(2):161-6.
1990: Hagenbeek A; Martens A C; Schultz F W; van Bekkum D W
Cure after allogeneic bone marrow transplantation: chemo-radiotherapy and/or graft-versus-leukemia?
Bone marrow transplantation 1990;6 Suppl 1():91-3.
1990: Martens A C; Van Bekkum D W; Hagenbeek A
The BN acute myelocytic leukemia (BNML) (a rat model for studying human acute myelocytic leukemia (AML)).
Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K 1990;4(4):241-57.
1990: Martens A C; van Bekkum D W; Hagenbeek A
Minimal residual disease in leukemia: studies in an animal model for acute myelocytic leukemia (BNML).
International journal of cell cloning 1990;8(1):27-38.
1990: Hagenbeck A; Martens A C
Minimal residual disease in acute leukemia: lessons learned from animal models.
Haematology and blood transfusion 1990;33():31-5.
1990: Arkesteijn G J; van Dekken H; Martens A C; Hagenbeek A
Clinical applications of flow karyotyping in myelocytic leukemia by stimulation of different subpopulations of cells in blood or bone marrow samples.
Cytometry 1990;11(1):196-201.
1990: Nooter K; de Vries A; Martens A C; Hagenbeek A
Effect of cyclophosphamide pretreatment on daunorubicin in rat acute leukaemia model.
European journal of cancer (Oxford, England : 1990) 1990;26(6):729-32.
1989: Hagenbeek A; Martens A C
Minimal residual disease in acute leukemia: from experimental models to man.
Bone marrow transplantation 1989;4 Suppl 3():68-9.
1989: Hagenbeek A; Martens A C
Cryopreservation of autologous marrow grafts in acute leukemia: survival of in vivo clonogenic leukemic cells and normal hemopoietic stem cells.
Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K 1989;3(7):535-7.
1989: Schultz F W; Martens A C; Hagenbeek A
The contribution of residual leukemic cells in the graft to leukemia relapse after autologous bone marrow transplantation: mathematical considerations.
Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K 1989;3(7):530-4.
1989: Hagenbeek A; Martens A C
On the heterogeneity of minimal residual disease in acute leukemia.
Bone marrow transplantation 1989;4 Suppl 1():9-12.
1988: Arkesteijn G J; Martens A C; Hagenbeek A
Bivariate flow karyotyping in human Philadelphia-positive chronic myelocytic leukemia.
Blood 1988;72(1):282-6.
1988: Hagenbeek A; Weiershausen U; Martens A C
Dinaline: a new oral drug against leukemia? Preclinical studies in a relevant rat model for human acute myelocytic leukemia (BNML).
Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K 1988;2(4):226-30.
1987: Arkesteijn G J; Martens A C; Jonker R R; Hagemeijer A; Hagenbeek A
Bivariate flow karyotyping of acute myelocytic leukemia in the BNML rat model.
Cytometry 1987;8(6):618-24.
1987: Martens A C; Schultz F W; Hagenbeek A
Nonhomogeneous distribution of leukemia in the bone marrow during minimal residual disease.
Blood 1987;70(4):1073-8.
1987: Hightower J A; Earnest D L; Martens A C; Zurcher C; Brouwer A; Blauw E; de Leeuw A M; Hagenbeek A
Effects of acute graft-vs-host disease on the liver of the brown Norway rat.
Journal of leukocyte biology 1987;42(2):128-43.
1987: Hagenbeek A; Martens A C; Colly L P
In vivo development of cytosine arabinoside resistance in the BN acute myelocytic leukemia.
Seminars in oncology 1987;14(2 Suppl 1):202-6.
1987: Martens A C; Hagenbeek A
Kinetics of normal hemopoietic stem cells during leukemia growth before and after induction of a complete remission. Studies in a rat model for acute myelocytic leukemia (BNML).
Leukemia research 1987;11(5):453-9.
1987: Hagenbeek A; Martens A C
On the fate of leukemic cells infused with the autologous marrow graft.
Haematology and blood transfusion 1987;30():553-9.
1986: Hagenbeek A; Martens A C
AMSA: in vivo log cell kill for leukemic clonogenic cells versus toxicity for normal hemopoietic stem cells in a rat model for human acute myelocytic leukemia (BNML).
European journal of cancer & clinical oncology 1986;22(10):1255-8.
1986: Martens A C; van Bekkum D W; Hagenbeek A
Heterogeneity within the spleen colony-forming cell population in rat bone marrow.
Experimental hematology 1986;14(8):714-8.
1986: Nooter K; Sonneveld P; Martens A; Hagenbeek A; Schultz F
Tissue distribution and myelotoxicity of daunomycin in the rat: rapid bolus injection vs continuous infusion.
European journal of cancer & clinical oncology 1986;22(7):801-6.
1986: Visser J W; Martens A C; Hagenbeek A
Detection of minimal residual disease in acute leukemia by flow cytometry.
Annals of the New York Academy of Sciences 1986;468():268-75.
1985: Nooter K; Sonneveld P; Martens A
Differences in the pharmacokinetics of daunomycin in normal and leukemic rats.
Cancer research 1985;45(9):4020-5.
1985: Martens A C; Hagenbeek A
Detection of minimal disease in acute leukemia using flow cytometry: studies in a rat model for human acute leukemia.
Cytometry 1985;6(4):342-7.
1985: Hagenbeek A; Martens A C
Detection of minimal residual disease in acute leukemia: possibilities and limitations.
European journal of cancer & clinical oncology 1985;21(3):389-95.
1985: Hagenbeek A; Martens A C
Reinfusion of leukemic cells with the autologous marrow graft: preclinical studies on lodging and regrowth of leukemia.
Leukemia research 1985;9(11):1389-95.
1984: Martens A C; Johnson R J; Kaizer H; Hagenbeek A
Characteristics of a monoclonal antibody (RM124) against acute myelocytic leukemia cells.
Experimental hematology 1984;12(8):667-71.
1984: Lopes Cardozo B; Martens A C; Zurcher C; Hagenbeek A
Secondary tumors after high-dose cyclophosphamide and total-body irradiation followed by bone marrow transplantation in a rat model for human acute myelocytic leukemia (BNML).
European journal of cancer & clinical oncology 1984;20(5):695-8.
1984: Nooter K; Sonneveld P; Deurloo J; Oostrum R; Schultz F; Martens A; Hagenbeek A
Repeated daunomycin administration in rats. Pharmacokinetics and bone marrow toxicity.
Cancer chemotherapy and pharmacology 1984;12(3):187-9.
1984: Kluin-Nelemans H C; Martens A C; Löwenberg B; Hagenbeek A
No preferential sensitivity of clonogenic AML cells to ASTA-Z-7557.
Leukemia research 1984;8(4):723-8.
1984: Hagenbeek A; Martens A C
Toxicity of ASTA Z 7557 (INN mafosfamide) to normal- and leukemic stem cells: implications for autologous bone marrow transplantation.
Investigational new drugs 1984;2(2):237-43.
1983: Hagenbeek A; Martens A C
Efficacy of high-dose cyclophosphamide in combination with total-body irradiation in the treatment of acute myelocytic leukemia: studies in a relevant rat model.
Cancer research 1983;43(1):408-12.
1983: Hagenbeek A; Martens A C
BCG treatment of residual disease in acute leukemia: studies in a rat model for human acute myelocytic leukemia (BNML).
Leukemia research 1983;7(4):547-55.
1982: Hagenbeek A; Martens A C
High-dose cyclophosphamide treatment of acute myelocytic leukemia. Studies in the BNML rat model.
European journal of cancer & clinical oncology 1982;18(8):763-9.
1981: Hagenbeek A; Martens A C
Extracorporeal irradiation of the blood in a rat model for human acute myelocytic leukemia. Increased efficacy after combination with cell mobilization by low-molecular-weight dextran sulfate.
Radiation research 1981;88(1):144-54.
1981: Hagenbeek A; Martens A C
The effect of fractionated versus unfractionated total body irradiation on the growth of the BN acute myelocytic leukemia.
International journal of radiation oncology, biology, physics 1981;7(8):1075-9.
1981: Martens A C; van den Engh G J; Hagenbeek A
The fluorescence intensity of propidium iodide bound to DNA depends on the concentration of sodium chloride.
Cytometry 1981;2(1):24-5.
1981: Hagenbeek A; Martens A C
Efficacy of piperazinedione prior to bone marrow transplantation: studies in a rat model for human acute myelocytic leukemia.
Cancer treatment reports 1981;65(7-8):575-82.
1981: Hagenbeek A; Martens A C
Separation of normal hemopoietic stem cells from clonogenic leukemic cells in a rat model for human acute myelocytic leukemia. II. Velocity sedimentation in combination with density gradient separation.
Experimental hematology 1981;9(6):573-80.
1981: Hagenbeek A; Martens A C
Extracorporeal irradiation of the blood in a rat model for human acute myelocytic leukemia. Comparative evaluation of three treatment regimens with emphasis on cell compartment analysis.
Radiation research 1981;85(3):480-95.
1981: Hagenbeek A; Martens A C; van Bekkum D W
Separation of normal hemopoietic stem cells from clonogenic leukemic cells in a rat model for human acute myelocytic leukemia.-I. Velocity sedimentation.
Leukemia research 1981;5(4-5):421-8.
1981: Hagenbeek A; Martens A C
The proliferative state of normal hemopoietic stem cells during progression of leukemia. Studies in the BN acute myelocytic leukemia (BNML).
Leukemia research 1981;5(2):141-8.
1980: Hagenbeek A; Martens A C
The pathogenesis of a rat model for human acute myelocytic leukemia.
Haematologica 1980;65(3):293-308.
1979: Hagenbeek A; Martens A C
A method for extracorporeal irradiation of the blood in the rat.
Radiation research 1979;80(1):198-207.
1979: Hagenbeek A; Martens A C
Functional cell compartments in a rat model for human acute myelocytic leukaemia.
Cell and tissue kinetics 1979;12(4):361-77.
1977: Ross W M; Martens A C; Robev S; Van Bekkum D W
Lymphocytosis induced by polyanions in rats.
Chemico-biological interactions 1977;16(2):123-33.
1975: Ross W M; Martens A C; van Bekkum D W
Polymethacrylic acid: induction of lymphocytosis and tissue distribution.
Cell and tissue kinetics 1975;8(5):467-77.

Sign-in to see more

Sign-in free and Explore the Exciting World of BiomedExperts:

NetworkView

Anton Martens

Research Profile (preview)

Living Beings

Disorders

Procedures

Anatomy

Chemicals & Drugs

Physiology

Network (preview)

Publications

Sign in free and see...

Visualized networks:

GeoTargeted Searches:

Research Profiles:

Geonetwork of Anton Martens (preview)

All Publications